The global and U.S. pharmaceutical packaging market has been registering speedy development. This includes innovations in production procedures and technological developments in modern times. Prefilled syringes are estimated to be one of the most rapidly developing sectors depending on the adoption of new bio-manufactured medicines and performance benefits in the systems of drug delivery.
The different packaging goods in this market have to be in agreement with stern policies implemented by the government. The global and U.S. pharmaceutical packaging market was valued at about USD 50.1 billion in 2012. It is projected to rise at about 6 percent CAGR during the forecast period. The market is anticipated to attain around USD 73 billion by 2018. The said phase lasts from 2012 to 2018.
The region of Asia Pacific is estimated to experience flow in demand for the global and U.S. pharmaceutical packaging market. This is due to augmentation in the number of pacts, expansion in pharmaceuticals in the region and escalating population of the elderly which depends heavily on pharmaceutical products.
Innovations like nano-facilitated packaging and some others are estimated to add revenue to the global and U.S. pharmaceutical packaging market. The market is fragmented on the basis of products and geography. On the basis of products, it is divided into blister packaging, plastic bottles, parental containers, labels, closures, other primary packaging and others.
The region sector of the global and U.S. pharmaceutical packaging market is segmented into four. These are North America, Europe, Asia Pacific and rest of the world. Plastic bottles and North America dominated the products and region sectors of the market respectively.
Posted on Mar 3, 2015 | Category Healthcare